Skip to main content

previous disabled Page of 2
and
  1. No Access

    Chapter and Conference Paper

    Name management and object technology for advanced software

    Name management is so fundamental to every aspect of computing that it is frequently overlooked or taken for granted. Our research is aimed at develo** both models to improve understanding and mechanisms to imp...

    Alan Kaplan, Jack C. Wileden in Object Technologies for Advanced Software (1993)

  2. No Access

    Chapter and Conference Paper

    Conch: Experimenting with Enhanced Name Management for Persistent Object Systems

    The name management capabilities currently provided by most existing persistent object systems (POSs) are rather limited. In particular, existing POSs tend to lack powerful and general mechanisms for forming, ...

    Alan Kaplan, Jack C. Wileden in Persistent Object Systems (1995)

  3. No Access

    Article

    Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancer

    Introduction: Patients with recurrent ovarian cancer were treated with a replication-deficient recombinant adenovirus containing the herpes simplex virus thymidine kinase gene administered intraperitoneally (i.p....

    Annette Hasenburg, **ao-Wen Tong, Augusto Rojas-Martinez in Cancer Gene Therapy (2000)

  4. No Access

    Chapter and Conference Paper

    Toward Pure Polylingual Persistence

    A heterogeneous persistent object system provides multiple programming language interfaces. This gives rise to the polylingual interoperability problem, namely, how can an application uniformly process data ob...

    Alan Kaplan, John V. E. Ridgway in Persistent Object Systems: Design, Impleme… (2001)

  5. No Access

    Article

    Toward Automated Support for Transparent Interoperable Queries

    Many Object-Oriented Databases (OODBs) use programming languages that predate Java, such as C++, CLOS and Smalltalk. Thus, there is a growing need for interoperating these OODBs with new applications that requ...

    Alan Kaplan, Bradley Schmerl, Rajesh Veeraraghavan in Information Technology and Management (2002)

  6. Article

    Open Access

    Can asthma control be improved by understanding the patient's perspective?

    Clinical trials show that asthma can be controlled in the majority of patients, but poorly controlled asthma still imposes a considerable burden. The level of asthma control achieved reflects the behaviour of ...

    Rob Horne, David Price, Jen Cleland, Rui Costa, Donna Covey in BMC Pulmonary Medicine (2007)

  7. Article

    Open Access

    Canadian clinical practice guidelines for acute and chronic rhinosinusitis

    This document provides healthcare practitioners with information regarding the management of acute rhinosinusitis (ARS) and chronic rhinosinusitis (CRS) to enable them to better meet the needs of this patient ...

    Martin Desrosiers, Gerald A Evans, Paul K Keith in Allergy, Asthma & Clinical Immunology (2011)

  8. Article

    Open Access

    Chronic obstructive pulmonary disease and exacerbations: Patient insights from the global Hidden Depths of COPD survey

    Although chronic obstructive pulmonary disease (COPD) is a major global health burden there is a lack of patient awareness of disease severity, particularly in relation to exacerbations.

    Neil Barnes, Peter MA Calverley, Alan Kaplan, Klaus F Rabe in BMC Pulmonary Medicine (2013)

  9. Article

    Open Access

    Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma?

    Despite current guidelines and the range of available treatments, over a half of patients with asthma continue to suffer from poor symptomatic control and remain at risk of future worsening. Although a number ...

    David Price, Leonard Fromer, Alan Kaplan in npj Primary Care Respiratory Medicine (2014)

  10. Article

    Open Access

    Quality of asthma care under different primary care models in Canada: a population-based study

    Previous research has shown variations in quality of care and patient outcomes under different primary care models. The objective of this study was to use previously validated, evidence-based performance indic...

    Teresa To, Jun Guan, **gqin Zhu, M Diane Lougheed, Alan Kaplan in BMC Family Practice (2015)

  11. Article

    Open Access

    A systematic review of comparative studies of tiotropium Respimat® and tiotropium HandiHaler® in patients with chronic obstructive pulmonary disease: does inhaler choice matter?

    In many countries worldwide, the long-acting anticholinergic drug tiotropium is available as a dry powder formulation delivered by means of the HandiHaler® inhalation device and as an aqueous solution delivere...

    Ronald Dahl, Alan Kaplan in BMC Pulmonary Medicine (2016)

  12. Article

    Open Access

    Cohort Analysis of Exacerbation Rates in Adolescent and Adult Patients Initiating Inhaled Corticosteroids for Asthma: Different Dose–Response Profile by Particle Size

    Targeting small airway inflammation could lead to improved clinical outcomes in asthma. Previous observational studies concluded that therapy with extrafine-particle [mass median aerodynamic diameter (MMAD) <...

    Dirkje S. Postma, Alan Kaplan, Joan B. Soriano, Jonathon Grigg in Pulmonary Therapy (2017)

  13. Article

    Open Access

    Solving the mystery of the yellow zone of the asthma action plan

    Samir Gupta, Alan Kaplan in npj Primary Care Respiratory Medicine (2018)

  14. Article

    Open Access

    A multi-stakeholder perspective on asthma care in Canada: findings from a mixed methods needs assessment in the treatment and management of asthma in adults

    Although several aspects of asthma care have been identified as being sub-optimal in Canada, such as patient education, practice guideline adoption, and access to care, there remains a need to determine the ex...

    Suzanne Murray, Sara Labbé, Alan Kaplan in Allergy, Asthma & Clinical Immunology (2018)

  15. Article

    Open Access

    A comparison of tiotropium, long-acting β2-agonists and leukotriene receptor antagonists on lung function and exacerbations in paediatric patients with asthma

    Diagnosing and treating asthma in paediatric patients remains challenging, with many children and adolescents remaining uncontrolled despite treatment. Selecting the most appropriate pharmacological treatment ...

    Christian Vogelberg, Stanley Goldstein, LeRoy Graham, Alan Kaplan in Respiratory Research (2020)

  16. Article

    Open Access

    Impact of comorbid conditions on asthmatic adults and children

    Comorbid conditions (comorbidities) can complicate the diagnosis and management of asthma. In different age groups, comorbid conditions can present varying challenges, including diagnostic confusion due to mim...

    Alan Kaplan, Stanley J. Szefler in npj Primary Care Respiratory Medicine (2020)

  17. Article

    Open Access

    Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management

    The Global Initiative for Asthma recommends a stepwise approach to adjust asthma treatment to the needs of individual patients; inhaled corticosteroids (ICS) remain the core pharmacological treatment. However,...

    Alan Kaplan, J. Mark FitzGerald, Roland Buhl in npj Primary Care Respiratory Medicine (2020)

  18. Article

    Open Access

    Switching Inhalers: A Practical Approach to Keep on UR RADAR

    The choice of an inhaler device is often as important as the medication put in it to achieve optimal outcomes for our patients with asthma and/or COPD. With a multitude of drug–device combinations available, o...

    Alan Kaplan, Job F. M. van Boven in Pulmonary Therapy (2020)

  19. Article

    Open Access

    A call to action for improving clinical outcomes in patients with asthma

    Andrew McIvor, Alan Kaplan in npj Primary Care Respiratory Medicine (2020)

  20. Article

    Open Access

    The Myth of Mild: Severe Exacerbations in Mild Asthma: An Underappreciated, but Preventable Problem

    Asthma is a common, chronic inflammatory airway disease, characterised by unpredictable episodes of worsening symptoms, or exacerbations. Causes of asthma exacerbations include viral infections, exposure to al...

    Alan Kaplan in Advances in Therapy (2021)

previous disabled Page of 2